Clinical Trial Update: Dextroamphetamine and tDCS to Improve the Fluency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dextroamphetamine and transcranial direct current stimulation (tDCS) to improve fluency in stroke patients has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Dextroamphetamine (Dextroamphetamine)
• Transcranial Direct Current Stimulation (transcranial direct current stimulation)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Stroke | Phase 2 | Status: COMPLETED | Results posted: 2018-08-03